AGP Executive Report
Last update: 19 minutes agoPublic Health Alert: The FDA issued a nationwide recall of nearly 300,000 dabigatran Etexilate blood thinner capsules after stability testing found impurity and degradation problems—patients are urged not to stop their meds without a clinician’s guidance. Local Health & Services: In the BVI, Health Minister Vincent O. Wheatley pushed for real development focus on Anegada and Virgin Gorda, warning the “biggest mistake” would be ignoring the Sister Islands. Energy & Health Access: WAPA announced a major overnight grid shutdown for parts of St. Thomas and all of St. John tied to the FEMA-funded Feeder 13 Bypass project, raising concerns for residents’ daily health needs during outages. Mental Health & Justice: A St. Croix case described a violent property dispute that escalated into threats and a court-ordered mental health hold. Environmental Health: Reports say sargassum is becoming self-sustaining and growing in large quantities across the Caribbean and Gulf—bad for tourism, marine life, and potentially public health as it rots. Drug Prices: A $400 million settlement in principle over generic drug price-fixing (Sandoz) adds pressure for fair competition in medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
